Architecture of clathrin-independent AP3:ARF1-coated carriers
Science Advances · 15.05.2026 · 12 (20)
DOI: 10.1126/sciadv.aed1529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 15.05.2026. Verfasst von Jonathan G G Kaufman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK. Hauptthemen laut MEDLINE: ADP-Ribosylation Factor 1, Clathrin, Adaptor Protein Complex 3. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Molecular Biology Organization, Wellcome, Medical Research Council.
Abstract (Originalsprache)
The AP3 complex mediates cargo sorting and carrier assembly for the trafficking of transmembrane proteins from endosomes to lysosomes. AP3 is generally believed to localize to clathrin-free, ARF1-positive, elongated carriers in cells, but the architecture of AP3-based coats was unknown. Using in vitro reconstitution and cryo–electron tomography, we demonstrate that AP3:ARF1 spontaneously remodels membranes containing cargo and the phosphoinositide PI(3,5)P 2 into tubular structures coated in spiraling rows of AP3 arches and ARF1 dimers. Targeted point mutations disrupting critical AP3:ARF1 and AP3:AP3 lattice interfaces disrupt AP3 recruitment, carrier formation, and lysosomal cargo trafficking in cells. We propose that AP3 generates tubular carriers on endosomes by organizing ARF1 dimers into elongated membrane-deforming arrays while simultaneously selecting cargo. By demonstrating that AP3:ARF1 can generate carriers without using a clathrin lattice, we explain the clathrin independence of AP3-mediated trafficking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cambridge Institute for Medical Research, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK.
- Department of Cell and Virus Structure, Max Planck Institute of Biochemistry, Martinsried 82512, Germany.
- MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK.
- Institute of Science and Technology, Klosterneuburg 3400, Austria.
- Institute for Biochemistry, Medical Faculty, University of Cologne, Cologne, Germany.
ORCID-Profile: Jonathan G G Kaufman, Grigory Tagiltsev, Rebecca J Taylor, Hui Guo, Katarzyna A Ciazynska, Nathan R Zaccai, Sally R Gray, Yvonne Vallis, Stefan Höning, Bernard T Kelly, David C Gershlick, John A G Briggs, David J Owen
Förderung
- European Molecular Biology Organization
- Wellcome
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Royal Society
- Max-Planck-Gesellschaft
Zitieren
APA
Kaufman, J. G. G., Tagiltsev, G., Stalder, D. S., Taylor, R. J., Sava, I., Guo, H., Ciazynska, K. A., Zaccai, N. R., Gray, S. R., Vallis, Y., Höning, S., Kelly, B. T., Gershlick, D. C., Briggs, J. A. G., & Owen, D. J. (2026). Architecture of clathrin-independent AP3:ARF1-coated carriers. Science Advances, 12(20). https://doi.org/10.1126/sciadv.aed1529
Vancouver
Kaufman JGG, Tagiltsev G, Stalder DS, Taylor RJ, Sava I, Guo H, et al. Architecture of clathrin-independent AP3:ARF1-coated carriers. Science Advances. 2026;12(20). doi:10.1126/sciadv.aed1529
BibTeX
@article{Kaufman2026,
author = {Kaufman, Jonathan G G and Tagiltsev, Grigory and Stalder, Danièle S and Taylor, Rebecca J and Sava, Ioana and Guo, Hui and Ciazynska, Katarzyna A and Zaccai, Nathan R and Gray, Sally R and Vallis, Yvonne and Höning, Stefan and Kelly, Bernard T and Gershlick, David C and Briggs, John A G and Owen, David J},
title = {Architecture of clathrin-independent AP3:ARF1-coated carriers},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {20},
doi = {10.1126/sciadv.aed1529}
}
EUVIMED